The hER is a ligand-dependent transactivator that belongs to a large superfamily of nuclear receptors. These family proteins bind various small hydrophobic ligands including the steroid hormones, thyroid hormone, vitamin D, and the retinoids for the activation. The hERs constantly shuttle between the cellular nucleus and the cytoplasm, but under steady-state conditions they are predominantly found in the nucleus.
In these nuclear receptor families, the estrogen and its receptor regulate the development, cell differentiation, and organ physiology. Recently, a number of environmental chemicals were found to be able to disrupt endocrine functions in experimental animals, wildlife, and humans. 4, 5 These chemicals, called "endocrine-disrupting chemicals" (EDCs), may act to alter blood hormone levels or the subsequent action of hormones. These chemicals are also believed to bind to the hER as an agonist or antagonist. Therefore, it is important to investigate many kinds of environmental chemicals for the purpose of screening potential estrogenic activity. In this context, a rapid, sensitive, and reliable in vitro screening method is required. 6 In previous reports, we have demonstrated a novel bioaffinity sensor that is based on the specific binding of test compounds to its receptor immobilized on a gold disk electrode. 7, 8 This biosensor offered several advantages over other binding assays. For example, our sensor system requires no chemical modification or radio-labeling of the test compounds for detection, and no separation procedures of the test compounds. Furthermore, the sensor can detect electrochemical signals after as little as 5 min of incubation. Unfortunately, this sensor system could not define whether the chemicals act as an agonist or antagonist. In order to screen the environmental toxicity of anthropogenic chemicals, it is necessary to know whether the compound induces or reduces the biological response of the hER. Ligand-induced transactivation of the hER is mediated through interactions with members of coactivator proteins including steroid receptor coactivator-1 (SRC-1), CREB binding protein (CBP), and receptor interacting protein 140 (RIP140). [9] [10] [11] Upon agonist binding, a conformational change in the ligand binding domain of hER, mainly E domain, creates a coactibator binding surface; transcriptional activation occurs after recruitment of coactivators to the receptor using this surface. On the other hand, the binding of antagonist ligands to the nuclear receptors leads a different conformational state that does not allow coactivators to interact. 9 In the present study, we constructed a new type of electrochemical sensing system that detected these protein-protein interactions using a piezo electric sensor. Its potential for the application to new screening system for EDCs is discussed.
Experimental

DNA construction and expression of recombinant proteins
Restriction enzymes were obtained from New England Biolabs (USA). Recombinant full-length hER, T4 DNA ligase, and Taq DNA polymerase were purchased from Takara (Japan). Hsp 90 was supplied from Sigma (St. Louis, USA). Laboratory chemicals were of reagent grade.
Plasmid pEThER-LBD, the bacterial expression vector containing the human ER ligand-binding domain (hER-LBD, amino acids 302-553) gene fused with oligohistidine sequence at the amino-terminus, has been constructed as described In vitro screening assays are useful techniques for the determination of receptor-mediated activities in environmental samples. In order to define whether environmental chemicals act as an agonist or antagonist to the human estrogen receptor (hER), we have constructed a biosensor based on ligand-inducible interactions between hER and relative proteins on a quartz crystal microbalance (QCM). The his-tagged proteins, which were expressed in E. coli by recombinant DNA technology, were immobilized on an Au-electrode with Ni(II)-mediated chemisorption using the histidine tag and thiol-modified iminodiacetic acid. The resonance-frequency change of the protein-modified electrode was caused by association or dissociation with the hER relative proteins on the surface in the presence of estrogen. These results suggest that this sensor is applicable as a large-scale screening tool for estrogenic compounds. previously. 7 This vector was allowed to express the hER-LBD in Escherichia coli BL21(DE3)pLysS cells (Novagen) using the T7 expression system. pEThSRC1-RID expressing his-tagged receptor binding domain of human SRC-1 (hSRC1-RID, amino acids 568-780) was cloned by PCR. The human cDNA library from Hela endocervical carcinoma cells was used as PCR template. The primers for hSRC1-RID that contained BamHI and XhoI sites are: 5′-GGATCCATTTCACCTAGCAAGATT-AAATATAC-3′ and 5′-CTCGAGCTGTTCTTTCTTTT-CCACTTTCA-3′ (restriction sites underlined). The PCRgenerated 0.64-kb fragment was then digested with BamHI and XhoI and was subcloned into pET29a vector (Novagen, USA). Correct insertion of the fragment was verified by DNA sequencing.
The resulting vector was allowed to express the hSRC1-RID in Escherichia coli BL21(DE3) cells (Novagen) using T7 expression system. Overnight cultures were diluted with 2YT medium including 30 µg/ml kanamycin to a volume of 800 ml and grown at 37˚C until an OD600 reached to 0.7; then the incubation temperature was decreased to 14˚C. Protein expression was induced by addition of isopropyl thiogalactopyranoside at a concentration of 1 mM. The tagged protein was purified with Hitrap chelating column essentially as described by the protocol from Amersham Pharmacia Biotech (England) under native conditions. The target protein was practically homogeneous and did not contain any breakdown products.
Electrode modification and QCM measurement
AT-cut 9 MHz quartz crystals (USI, Japan) were vacuum deposited with gold electrodes on both sides (diameter, 4.5 mm). The resonant frequency was monitored with a universal frequency counter (Hewlett-Packard, Model 53131A) attached to a personal computer.
Histidine-tagged hER-LBD and hSRC1-RID were immobilized onto Au-surface on the quartz cristal via metal (Ni 2+ ) complexation. 3,3′-Dithiobis[N-(5-amino-5-carboxypentyl)-propionamide-N′,N′-diacetic acid] dihydrochloride (disulfide-NTA) was purchased from DOJINDO (Japan). The disulfide-NTA was immobilized onto the Au surface via chemisorption. Thus, the cleaned bare Au surface of the QCM plate was immersed in 100 µM aqueous disulfide-NTA solution for 10 min at room temperature, followed by washing carefully with distilled water. The quartz crystal was then immersed into 0.1 M aq. NiSO4 for 10 min at room temperature. The resulting Ni-NTA-modified quartz crystal was kept in buffer solution (20 mM HEPES-KOH (pH 7.7), 75 mM NaCl, 2.5 mM MgCl2, 1 mM DTT, 0.05% NP40) and finally was set to the QCM system. After the resonant frequency reached a constant value, histagged proteins in buffer solutions were added. All the QCM measurements were carried out at 4˚C.
Results and Discussion
The SRC1 is one of the transcriptional coactivators that are capable of modulating the activity of nuclear receptors including hER. A receptor interaction domain (RID) of SRC1 participates to the ligand-dependent, direct interactions with nuclear receptors. 13 In this study, we constructed an expression vector, pEThSRC1-RID, in which the RID of hSRC1 could be expressed in E. coli as the in-frame fusion with ten consecutive histidine residues at the amino-terminus. E. coli [BL21(DE3)] were transformed with pEThSRC1-RID and then grown in the presence or absence of 1 mM IPTG. As expected, the SDS-PAGE analysis of the total cell extracts showed the recombinant fusion protein hSRC1-RID with the predicted molecular weight (27 kDa) only in cell extracts prepared from IPTG-treated cells (Fig. 1, lane 3) . The fusion protein was purified by affinity chromatography under native conditions. The soluble fraction of a crude lysate was loaded on a NTA-carrying resin. hSRC1-RID containing a histidine affinity tag was effectively bound to the resin. After the removal of background proteins with 80 mM aq. imidazole solution, the desired histidine-tagged protein was eluted from the column with 250 mM of aqueous imidazole, which competes with the tagged proteins for binding sites on the NTA resin (Fig. 1, lanes 4 -6) . The hSRC1-RID was obtained as a nearly homogenous species and did not contain any breakdown products. The concentration of the purified fusion protein was determined by the method of Bradford to be 2.2 -3.0 mg/l-cell culture.
Prior to estrogen binding, the hER exists as an inactive oligomeric complex containing hsp90. If estrogen derivatives bind to hER, they dissociate from the receptor and the hER then forms homodimer, which can bind to specificD DNA sequence directly. The ligand-binding domain (LBD) in the hER is responsible for high-affinity binding of estrogen and has been implicated in transcriptional activation, protein dimerization, and interaction with hsp90. In order to detect the liganddependent interaction between the hER and hsp90, QCM measurement was carried out using the quartz crystal modified with the protein-complex consisting of hER-LBD and hsp90 in the presence of 17β-estradiol.
Prior to the protein immobilization, equal amounts of hER-LBD and hsp90 were incubated in buffer solution (20 mM HEPES-KOH (pH 7.7), 75 mM NaCl, 2.5 mM MgCl2, 1 mM DTT, 0.05 % NP40) overnight at 4˚C. Figure 2 shows the frequency change of the NTA-modified QCM during the adsorption of the complex and the ligand-dependent desorption of the hsp90 from the complex on the gold surface in the aqueous solution at 4˚C. The frequency of the QCM decreased gradually for ca. 10 min due to the adsorption of the complex on the NTA-modified surface. According to Sauerbrey's equation, 15 the adsorption amount under the equilibrium condition was calculated to be 244 ng from the frequency decrease after protein binding. Assuming that hER-LBD and hsp90 form the 1:1 complex in molar ratio, 2 pmol of the complex should be immobilized on the gold surface of the QCM. When 17β-estradiol was added to the solution at a final concentration of 1 µM, the frequency was increased rapidly and reached a plateau within 2 min. It may be due to the desorption of the hsp90 from the immobilized hER. The frequency change suggests that 46.4 ng (0.5 pmol) of hsp90 was dissociated from the complex.
As the next experiment, the interaction between hER and SRC-1 was investigated. The binding of estrogen to hER induces a conformational change in LBD that allows SRC1 to interact.
14 To monitor this process, we prepared hSRC1-RID modified QCM and tried monitering the interaction with recombinant full-length hER in the presence of estrogen under physiological conditions. Figure 3 shows the frequency change of the QCM during the binding of the hER on hSRC1-RID modified QCM after addition of 17β-estradiol. When 10 nM 17β-estradiol was injected to the solution, the frequency decreased gradually, reflecting the slow binding of the hER on the hSRC1-RID modified gold surface. The adsorption amount of the hER was calculated to be 99 ng (2.2 pmol) from ∆F. In contrast, hSRC1-RID modified QCM showed no response to the 17β-estradiol in the absence of the hER. These results indicate that this QCM system can specifically detect the ligand-induced interaction between nuclear receptor and its coactivator.
A QCM is a sensitive surface sensor that is capable of measuring nanogram levels of mass change on the surface. In order to define the estrogenic potency of a number of anthropogenic chemicals, there is a great need for an effective screening assay for the purpose. While it is clear that in vivo screens may be required to characterize a compound as an endocrine disruptor that can cause adverse effects in exposed organisms, in vitro assays are required to define the molecular mechanisms responsible for these effects, so finally we can screen the chemicals on large scale. However, conventional competitive ligand binding assays can not define whether the compounds act as an agonist or antagonist. The novel sensor based on the protein-protein interaction presented here is applicable as a convenient tool for the evaluation of the hER binding ability (agonistic activity of hER) of chemicals. This sensor is an efficient screening system to identify the potential activity of a number of chemicals as hER-ligands and to provide basic information for further analysis and risk evaluation. Fig. 3 Frequency shift during adsorption process of hER on hSRC1-RID-modified surface in the presence of 17β-estradiol. Frequency shifts were measured just after the addition of 0.14 nM full-lengh hER and 10 nM 17β-estradiol to the measurement solution at 4˚C.
